13-110424850-G-A

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001846.4(COL4A2):​c.297G>A​(p.Thr99Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.961 in 1,614,068 control chromosomes in the GnomAD database, including 745,245 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.94 ( 67054 hom., cov: 31)
Exomes 𝑓: 0.96 ( 678191 hom. )

Consequence

COL4A2
NM_001846.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.795

Publications

24 publications found
Variant links:
Genes affected
COL4A2 (HGNC:2203): (collagen type IV alpha 2 chain) This gene encodes one of the six subunits of type IV collagen, the major structural component of basement membranes. The C-terminal portion of the protein, known as canstatin, is an inhibitor of angiogenesis and tumor growth. Like the other members of the type IV collagen gene family, this gene is organized in a head-to-head conformation with another type IV collagen gene so that each gene pair shares a common promoter. [provided by RefSeq, Jul 2008]
COL4A2 Gene-Disease associations (from GenCC):
  • porencephaly 2
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • COL4A1 or COL4A2-related cerebral small vessel disease
    Inheritance: AD Classification: MODERATE Submitted by: Illumina
  • familial porencephaly
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 13-110424850-G-A is Benign according to our data. Variant chr13-110424850-G-A is described in ClinVar as Benign. ClinVar VariationId is 311096.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.795 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.977 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL4A2NM_001846.4 linkc.297G>A p.Thr99Thr synonymous_variant Exon 5 of 48 ENST00000360467.7 NP_001837.2 P08572A0A024RDW8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL4A2ENST00000360467.7 linkc.297G>A p.Thr99Thr synonymous_variant Exon 5 of 48 5 NM_001846.4 ENSP00000353654.5 P08572

Frequencies

GnomAD3 genomes
AF:
0.937
AC:
142587
AN:
152124
Hom.:
67015
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.859
Gnomad AMI
AF:
0.985
Gnomad AMR
AF:
0.964
Gnomad ASJ
AF:
0.979
Gnomad EAS
AF:
0.999
Gnomad SAS
AF:
0.973
Gnomad FIN
AF:
0.987
Gnomad MID
AF:
0.962
Gnomad NFE
AF:
0.961
Gnomad OTH
AF:
0.950
GnomAD2 exomes
AF:
0.964
AC:
240599
AN:
249490
AF XY:
0.965
show subpopulations
Gnomad AFR exome
AF:
0.854
Gnomad AMR exome
AF:
0.981
Gnomad ASJ exome
AF:
0.981
Gnomad EAS exome
AF:
1.00
Gnomad FIN exome
AF:
0.985
Gnomad NFE exome
AF:
0.961
Gnomad OTH exome
AF:
0.971
GnomAD4 exome
AF:
0.963
AC:
1407681
AN:
1461826
Hom.:
678191
Cov.:
50
AF XY:
0.963
AC XY:
700486
AN XY:
727218
show subpopulations
African (AFR)
AF:
0.851
AC:
28476
AN:
33474
American (AMR)
AF:
0.981
AC:
43866
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.981
AC:
25635
AN:
26132
East Asian (EAS)
AF:
1.00
AC:
39695
AN:
39700
South Asian (SAS)
AF:
0.971
AC:
83791
AN:
86254
European-Finnish (FIN)
AF:
0.984
AC:
52559
AN:
53414
Middle Eastern (MID)
AF:
0.959
AC:
5531
AN:
5768
European-Non Finnish (NFE)
AF:
0.962
AC:
1070203
AN:
1111968
Other (OTH)
AF:
0.959
AC:
57925
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
2597
5194
7790
10387
12984
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21632
43264
64896
86528
108160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.937
AC:
142684
AN:
152242
Hom.:
67054
Cov.:
31
AF XY:
0.938
AC XY:
69838
AN XY:
74430
show subpopulations
African (AFR)
AF:
0.859
AC:
35675
AN:
41542
American (AMR)
AF:
0.964
AC:
14759
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.979
AC:
3399
AN:
3472
East Asian (EAS)
AF:
0.999
AC:
5149
AN:
5152
South Asian (SAS)
AF:
0.973
AC:
4695
AN:
4824
European-Finnish (FIN)
AF:
0.987
AC:
10484
AN:
10618
Middle Eastern (MID)
AF:
0.963
AC:
283
AN:
294
European-Non Finnish (NFE)
AF:
0.961
AC:
65339
AN:
68014
Other (OTH)
AF:
0.950
AC:
2003
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
434
869
1303
1738
2172
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
912
1824
2736
3648
4560
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.950
Hom.:
60425
Bravo
AF:
0.934
Asia WGS
AF:
0.977
AC:
3397
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Porencephaly 2 Benign:2
Jul 22, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
0.090
DANN
Benign
0.66
PhyloP100
-0.80
PromoterAI
-0.0043
Neutral
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4238272; hg19: chr13-111077197; COSMIC: COSV108196709; COSMIC: COSV108196709; API